Objective. This study proposes three indicators of, and assesses the disparities and trends in, the risk of HIV infection progression among people living with diagnosed HIV infection in the United States.
In the United States, the number of people aged 13 years and older living with human immunodeficiency virus (HIV) infection was estimated to be more than 1.1 million as of December 2010, a 9% increase from 2006. 1 For people living with HIV, increasing their access to care and eliminating disparities are primary goals of the National HIV/AIDS Strategy (NHAS) and the Healthy People 2020 objectives. 2, 3 Assuring that all people with HIV are diagnosed early, promptly linked to care, retained in care, and offered antiretroviral treatment is essential to achieve the ultimate goal of the continuum of care, 4 leading to viral suppression, improved health, survival, and prevention of HIV transmission.
Several studies have used national HIV surveillance data to examine the disparities and determinants of progression to acquired immunodeficiency syndrome (AIDS; i.e., stage 3 HIV infection 5 ) and death after HIV diagnosis. These studies have focused on individuals diagnosed in a certain time period and have examined the differences in time from HIV diagnoses to AIDS and death (i.e., the number of months/years from HIV diagnosis to AIDS or death) using survival analyses, including Kaplan-Meier survival curves, the Cox proportional hazard model, or the standardized relative risk. [6] [7] [8] However, previous studies have not assessed the risks of progression to AIDS and death among all people living with HIV, and have not reported the trends in these outcomes.
To fill this gap, we propose in this study three crosssectional indicators to estimate the risks of progression to AIDS and death in a calendar year after HIV diagnoses among people living with diagnosed HIV infection, regardless of their time of diagnosis (i.e., the year when an HIV infection was first diagnosed). The results allow for an annual assessment of the risks of HIV infection progression and can be used to monitor the trends in these outcomes among people living with HIV.
Specifically, this study (1) examined the disparities in the risk of progression to AIDS in 2010 among people living with diagnosed HIV (not AIDS) infection at yearend 2009 (AIDS diagnosis hazard), the risk of death in 2010 among those living with diagnosed HIV (including AIDS) infection at year-end 2009 (HIV death hazard), and the risk of death in 2010 among individuals living with AIDS at year-end 2009 (AIDS death hazard); and (2) assessed the trends in the risks of HIV infection progression among people living with diagnosed HIV infection from 1997 to 2010 using the three indicators.
METHODS

Outcome measures
The AIDS diagnosis hazard measures the risk of progression from HIV (not AIDS) to AIDS in a year among those living with a diagnosis of HIV (not AIDS) infection at the beginning of the year. It is calculated as the proportion of AIDS diagnoses in year t among individuals living with diagnosed HIV (not AIDS) infection at the end of year t 2 1. That is: AIDS diagnosis hazard 5 number of AIDS diagnoses in year t among people living with HIV (not AIDS) at year-end (t -1)
number of people living with HIV (not AIDS) at year-end (t -1)
The HIV death hazard measures the risk of death in a year among people living with a diagnosis of HIV infection (including AIDS) at the beginning of the year. It is calculated as the proportion of deaths in year t among individuals living with diagnosed HIV (including AIDS) infection at the end of year t 2 1. That is:
HIV death hazard 5 number of deaths in year t among people living with HIV (including AIDS) at year-end (t -1) number of people living with HIV (including AIDS) at year-end (t -1)
The AIDS death hazard measures the risk of death in a year among those who have ever been diagnosed with AIDS and are alive at the beginning of the year. It is calculated as the proportion of deaths in year t among people living with AIDS at the end of year t 2 1. For each measure and each population group stratified by current age, race/ethnicity, mode of transmission, region of residence at diagnosis, and year of diagnosis, respectively, we estimated the numerators and denominators separately as defined in the outcome measures section and calculated the corresponding hazard. We adjusted all numerators and denominators to account for the delay in reporting of cases and deaths to CDC. We used multiple imputation to assign a transmission category to those with missing risk information. 9, 10 For each demographic stratification, we calculated the hazard ratios (HRs) using one group as the reference. We calculated the standard errors of the HRs using the delta method. 11 We calculated the 95% confidence intervals (CIs) assuming that the HRs follow log-normal distributions.
We included data from 50 U.S. states and the District of Columbia where possible except for AIDS diagnosis hazard and HIV death hazard stratified by year of diagnosis, for which we included data from 26 states that have had confidential name-based HIV reporting since 1996. About 27% of all HIV cases diagnosed in the United States in 2011 occurred in the 26 states. We limited the analysis by year of diagnosis starting from 1996, because that is when highly active antiretroviral therapy (HAART) became widely available.
To assess any change in the risks of progression to AIDS and death from 1997 to 2010, we calculated the AIDS diagnosis hazard, HIV death hazard, and AIDS death hazard for each calendar year during the years 1997-2010 using data from 26 states that implemented confidential name-based HIV reporting since 1996. All hazard estimates were log-transformed to estimate the annual percentage change and to satisfy the normal assumption of the linear regression. For each hazard, a linear regression was conducted with log-transformed hazard as the dependent variable and the calendar year as the independent variable to test the significance of the trend and to estimate the annual percentage change. The significance of a trend was assessed at p,0.05. We calculated the estimated annual percentage change as the exponential of the parameter estimate for the calendar year. The 95% CI for the estimated annual percentage change was based on a t-distribution with 14 degrees of freedom.
RESULTS
In the United States, an estimated 372,502 people were living with diagnosed HIV (not AIDS) infection at yearend 2009; among them, about 4.2% progressed to AIDS in 2010. An estimated 846,065 people were living with diagnosed HIV (including AIDS) infection at year-end 2009; among them, 2.1% died in 2010. An estimated 473,758 people were living with AIDS at year-end 2009; among them, 2.8% died in 2010 (Table) . The AIDS diagnosis hazard in 2010 was higher among those aged 15-54 years, particularly those aged 15-29 years, than among those aged #14 or $55 years. The HIV death and AIDS death hazards increased consistently with increasing age. Compared with white people, black/ African American individuals and those of multiple races had a higher hazard of AIDS diagnosis, HIV death, and AIDS death in 2010; Hispanic/Latino people had a higher AIDS diagnosis hazard but lower HIV death hazard and AIDS death hazard; American Indians/Alaska Natives had a higher AIDS diagnosis hazard and HIV death hazard; and Asians had a lower HIV death hazard and AIDS death hazard.
Compared with men who have sex with men (MSM), males with infection attributed to injection drug use (IDU), MSM who engaged in IDU, and those with infection attributed to heterosexual contact had a significantly higher AIDS diagnosis hazard, HIV death hazard, and AIDS death hazard (Table) . Among females, all three hazards in 2010 were significantly higher among women with infection attributed to IDU than among those with infection attributed to heterosexual contact. By region of residence, the 2010 hazard of HIV infection progression was significantly higher in the South than in the Northeast. Compared with the Northeast, the 2010 HIV death hazard and AIDS death hazard in the Midwest and in the West were significantly lower.
The 2010 AIDS diagnosis hazard in the 26 states decreased consistently for earlier years of diagnosis (Table) 
DISCUSSION
For this study, we propose three simple measures of the risks of HIV infection progression to AIDS and death among those living with diagnosed HIV infection in the United States, and we assess the disparities and trends in those measures. To our knowledge, this study is the first to assess the trends in these outcomes among people living with HIV. We found that the risks of HIV infection progression among individuals living with HIV decreased significantly from 1997 to 2010 in the United States; however, several disparities persisted in 2010. These results provide useful information regarding the need to provide care and treatment to all individuals living with HIV and, in particular, to those with more adverse outcomes.
Decreasing AIDS diagnosis hazard, HIV death hazard, and AIDS death hazard among people living with diagnosed HIV infection might be related to increased HIV testing in the past 10 years in the United States, 12 early initiation of HIV treatment after HIV diagnosis, or the improved use of health services among the HIV-infected population. 13, 14 A study found that CD4 count at first presentation for HIV care has increased annually from 1997 to 2007 in the United States (higher CD4 presentation indicates earlier detection of HIV infection). 13 Although this study could not separate the mortality caused by other factors or general aging caused by HIV infection, changes in immune system functioning related to aging may contribute to the significantly higher HIV death and AIDS death hazards among older individuals. 15 Existing studies also suggest that older people are more likely to have delayed diagnoses, 16, 17 and older age is a strong risk factor for disease progression. 8 On the other hand, we found that among those living with HIV (not AIDS) at year-end 2009, the risk of progression to AIDS in 2010 was highest among people aged 15-29 years, and it decreased with increasing age. Progression from HIV (not AIDS) to AIDS might be related to delayed diagnosis, or access or adherence to HIV medical treatment. Because young people aged 15-24 years were least likely to have delayed diagnosis 18 and prevalence of viral suppression (13%) was lowest among those aged 18-24 years, 19 the higher risk of progression to AIDS largely suggests a lack of adequate access to care or adherence to HIV treatment among young people living with HIV. 1, [20] [21] [22] [23] Higher risks of progression to AIDS and death among males with infection attributed to IDU or heterosexual contact, and among females with infection attributed to IDU, might be due to delayed diagnosis, 1 delayed linkage to HIV medical care, 1,24,25 less use of health services among heterosexuals and those who inject drugs, 14, 26 and high-risk lifestyle factors or death from comorbidity conditions such as hepatitis C coinfection among people who inject drugs. 27, 28 Observed disparities in the risks of progression to AIDS and death among people of multiple races and African Americans might reflect the disparities in delayed diagnosis, 18 access or linkage to medical care, 26 adherence to treatment, 22 and other socioeconomic factors that might affect access to HIV care. 20, 21, 26, 29 In addition, the higher risks of progression to AIDS and death in the South may reflect their delayed access to HAART or decreased likelihood of using HAART. 13, 30 We found that in 2010, people who had been diagnosed in 2009 had the highest AIDS diagnosis hazard and AIDS death hazard and a higher HIV death hazard than those diagnosed during 2004-2008. This finding is consistent with a previous finding that the death rate in 2007 was significantly higher for individuals diagnosed with AIDS in 2006 than for those diagnosed with AIDS during 1997-2005. 31 Higher risks of progression to AIDS and death within the first year of diagnosis might be due to delayed diagnosis, which significantly increases the risk of progression to AIDS and death soon after diagnosis, while those diagnosed in earlier years already died or had time to enter care and treatment. Decreasing AIDS diagnosis hazard for the earlier year of diagnosis could indicate the effectiveness of early HIV diagnosis and receiving medical care to delay disease progression.
Limitations
This study was subject to several limitations. First, data were adjusted for delays in case and death reporting, and transmission category was imputed for cases with no risk information. Statistical adjustment and imputation of the missing data were used to reduce bias, but the adjustment might have introduced uncertainties into the results. Second, the calculation of the death hazard included death from all causes, not just death from HIV. Therefore, the death hazard measured the risk of all-cause death among people with HIV. Third, data to assess AIDS diagnosis hazard and HIV death hazard by year of diagnosis and for the trend analyses were only available from 26 states. As such, the results may not be generalizable to the United States as a whole.
CONCLUSION
Improving health outcomes among people living with HIV is important for the health of the individual and to prevent further HIV transmission. Although decreased risks of progression to AIDS and death were observed among people living with HIV from 1997 to 2000 in the United States, the reported level of viral suppression among them was low (30%) in 2011. 19 Disparities in the 2010 risks of HIV infection progression might reflect the differences in access to and use of testing and care among individuals with HIV. Continued efforts are needed to ensure early HIV diagnosis and initial linkage to and continued engagement in HIV medical care among those living with HIV. Targeted interventions are needed to improve health-care and supportive services for those with worse health outcomes.
